Answer
In studies evaluating the terminal elimination phase, tivozanib had a mean half-life of 4.5–5.1 days.
Sources for this answer
- Fotivda 890mcg hard capsulesRecordati UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 13Document updated
Sources checked